Evaluating Anticoagulant Efficacy in Antiphospholipid Syndrome

This chapter examines a randomized controlled trial investigating the transition from warfarin to rivaroxaban in patients with antiphospholipid antibody syndrome. It critiques the study's design, findings related to arterial events, and the need for larger trials to determine the optimal anticoagulant therapy for high-risk patients.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.